Bivatuzumab (Anti-CD44v6)
Bivatuzumab (Anti-CD44v6) (A2555-GRP)
Products
Description
Bivatuzumab (Anti-CD44v6) is a humanized monoclonal antibody targeting against CD44v6 that could acts as a sarcoma target for CAR-redirected CIK cells. MW:145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2555 |